Ben Feringa (left), Nobel Prize in Chemistry winner in 2016, will be one of the speakers at the second International Symposium on Photopharmacology (ISPP2018) on 1st-2nd November.
Co-organised by IBEC, UVic-UCC and IQAC-CISC, the symposium will take place in the Torre dels Frares building at the UVic and will be attended by more than 120 people, the vast majority of whom will be coming from countries other than Spain.
Introducing a drug into the human body that remains inactive inside it and only acts when, where and how we tell it to will be possible within a few years with the application of photopharmacology, a new branch of science that uses light to control the activity of medication.
The symposium will be a meeting place and debate forum for leading researchers and figures in this emerging field, and the organisers hope it will foster synergies and cooperation between centres and researchers, as well as establishing a debate to delineate problems, define solutions, align strategies and consider future developments.
The symposium will include around twenty lectures, three blocks of short presentations and two poster sessions. As well as Ben Feringa of the University of Groningen in the Netherlands, who was awarded the Nobel Prize in Chemistry in 2016 for the design and synthesis of molecular machines alongside Jean-Pierre Sauvage and Fraser Stoddart, the speakers will include Edith C. Glazer of the University of Kentucky, who is working on the development of complex metals such as possible photoactive drugs, and Austria’s Dirk Trauner of the University of New York, who is focused on the application of photopharmacology in neurobiology. One of the main achievements of his team, working with Richard Kramer and Ehud Isacoff, has been to restore sight in blind animals, using drugs that respond to visible light as molecular prostheses.
The symposium will also include the points of view of professionals from areas of influence within photopharmacology, such as doctors, representatives of industrial sectors linked to light (photonics, spectroscopy and optics), molecular therapy (the pharmaceutical industry, biotechnology and medical chemistry) and medical devices.
Visit the website for more information: http://events.ibecbarcelona.eu/ispp2018/
IBEC In the Media
La Vanguardia (28/10/2018) “Fijar medicamentos dentro del cuerpo será posible con la fotofarmacología”
La Vanguardia (02/11/2018) “Fármacos regulados por luz tratarán ceguera, cáncer, diabetes y dolor crónico”
El Periódico (02/11/2018) “Fármacos regulados por luz tratarán ceguera, cáncer, diabetes y dolor crónico”
RAC1 (04/11/2018) “D’aquí 10 anys: fotofarmacolgia“